Malaria, Vivax
9 treatments and conditions followed through the public trial records. Not medical advice.How a status is set
Lists this condition and the narrower ones beneath it. A condition is not a diagnosis.
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| Artemether + Lumefantrine for malaria, vivax | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Artemether + Lumefantrine + TAFENOQUINE for malaria, vivax | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Dihydroartemisinin + Piperaquine tetraphosphate for malaria, vivax | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Dihydroartemisinin + Piperaquine tetraphosphate + TAFENOQUINE for malaria, vivax | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Primaquine for malaria, vivax | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 2 |
| Pvs230D1-EPA/Matrix-M for malaria, vivax | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Tafenoquine for malaria, vivax | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 6 |
| Tafenoquine + chloroquine for malaria, vivax | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Tafenoquine succinate for malaria, vivax | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |